1-(2-Bromo-5-chlorophenyl)ethanone, 95.0%, 25g

2,2-dichloroacetamide, 98.0%, 10g

[2-(piperidin-1-ylcarbonyl)phenyl]amine, 5g

tert-Butyl 4-amino-4-(pyridin-3-ylmethyl)piperidine-1-carboxylate, 1g

(3S)-(+)-1-Benzyl-3-(ethylamino)pyrrolidine>95.0%(GC)5g

Methyl 4-amino-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 98%, 250mg

2-Methyl-2-imidazoline>97.0%(GC)(T)25g

4-(1H-1,2,4-Triazol-1-yl)phenol, 97%, 5g

(2E)-1-(4-nitrophenyl)-3-(thiophen-2-yl)prop-2-en-1-one, 95.0%, 10g

4-Bromo-5-chloro-2-nitroaniline, 90.0%, 100g

1-Methylpiperidin-3-one, 97.0%, 250mg

(2R,3R,4R,5S,6S)-2-(acetoxymethyl)-6-(4-methyl-3-((5-phenylthiophen-2-yl)methyl)phenyl)tetrahydro-2H-pyran-3,4,5-triyl triacetate, 98%, 5mg

1-bromo-3-cloropropano, minimo 99%, per sintesi, 250 ml, confezione in vetro